The independent source for health policy research, polling, and news.
701 - 720 of 112,415 Results
The Trump administration may impose sector-specific tariffs if pharmaceutical companies stray from most-favored-nation pricing for prescriptions, Managed Healthcare Executive reported. The administration is also looking at other statutes that would allow the use of tariffs to further its policy priorities.
More than half of the states have confirmed measles cases, with South Carolina, Utah, and Arizona experiencing widespread outbreaks. Meanwhile, five more children have died from the flu, which is still circulating at high levels across much of the country.
Today's early morning highlights from the major news organizations.
Companies are now marketing “clean,” “modern” nicotine pouches with minimalist packaging, aimed at helping people “lock in” and achieve their goals. The catch is that most of these products have not been cleared by the FDA for sale in the U.S.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on Black paramedics, limb lengthening, mammograms, gene-editing, and more.
Opinion writers tackle these public health topics.
Glyphosate is the most commonly used herbicide for a slew of U.S. crops and also the chemical in the weed killer Roundup, which is under fire in scores of lawsuits that allege it causes cancer. Ken Cook, president of the Environmental Working Group, called the move a “middle finger to every MAHA mom.”
The new Department of Veterans Affairs rule would have factored in whether medication effectively treats an ailment in determining compensation for veterans with a disability. “Disabled veterans should never be forced to choose between following their doctor’s orders and protecting their earned benefits,” VFW National Commander Carol Whitmore said.
Tracy Beth Høeg, the fifth director of the Center for Drug Evaluation and Research since last year, says she is prioritizing the health of women and babies. Meanwhile, ACIP is postponing its meeting set for next week. Plus, measles cases continue to spread.
The last set of holdouts picketing for better working conditions will vote on whether to ratify the agreement in the coming days. Other companies making headlines include EmblemHealth, Community Health Systems, UnitedHealthcare, Change Healthcare, Banner Health, and more.
The Medicaid measure would extend coverage for new moms up to a year after giving birth. The second bill requires insurance companies to cover extra cancer screenings for women with dense breast tissue. Democratic Gov. Tony Evers is expected to sign them next week, AP reported.
Today's early morning highlights from the major news organizations.
Although the findings are not yet accurate enough to predict a patient’s exact trajectory, The Washington Post reports that scientists created a model that could use blood test results to forecast the start of symptoms within a margin of three to four years. Other public health news is on social media, foodborne bacteria, and more.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers examine these public health issues.
In changing the longtime standard, administration officials aim to speed up the approval process. Also in the news: domestic production of glyphosate, fluoride in drinking water, and more.
Although nearly all racial and ethnic groups experienced a downward trend, minority groups had more of a decrease in early prenatal care. The report didn't touch on reasons for the shift in care, but doctors noted access has become challenging as maternity care deserts pop up across the nation.
More than 20 health systems have joined forces to improve health care access in rural and underserved communities, Modern Healthcare reported.
Months after the Trump administration proposed a withdrawal of federal funds from hospitals providing gender transition treatments to young people, NYU Langone has announced the end of its health program. Advocates are calling for the reinstatement of the program, while hoping the city and state will help fill gaps in care.
Jay Bhattacharya's acting role gives the Trump administration time to find a permanent replacement for ousted director Jim O'Neill. Plus, Moderna's mRNA flu vaccine application will be reviewed by the FDA after all.
© 2026 KFF